← Leaderboards
Daniel H Mathalon
Yale University
$8,369,757
Attributed
$9,580,003
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,580,003 · 8
By mechanism
U01$3,906,299 · 1
R01$2,924,917 · 2
R25$863,857 · 1
R56$763,021 · 1
P50$547,034 · 1
R21$421,575 · 1
Top collaborators
- Susan M. Voglmaier4 shared
- Stuart James Eisendrath2 shared
- Judith M Ford2 shared
- Thomas C Neylan1 shared
Most similar at Yale University
Same institution · by research overlap
- Scott W Woods$46,801,415
- Albert R Powers$12,336,008
- John H Krystal$70,915,889
- Philip Corlett$6,502,664
- Rong Fan$22,943,481
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainBaseProgramsSchizophreniaResearch PersonnelFunctional DisorderPrefrontal CortexFollow-UpSymptomsEvent-Related PotentialsVisualAntipsychotic AgentsAccountingClinical AssessmentsResponseNeurobiologySyndromeAttentionPsychotic DisordersHigh RiskInstrumentPharmaceutical PreparationsNormal AgingGenetic
Grant awards (25)
TRAINING THE NEXT GENERATION OF MENTAL HEALTH RESEARCHERS$215,950
R25 · FY2025 · MH
TRAINING THE NEXT GENERATION OF MENTAL HEALTH RESEARCHERS$215,952
R25 · FY2024 · MH
TRAINING THE NEXT GENERATION OF MENTAL HEALTH RESEARCHERS$215,955
R25 · FY2023 · MH
TRAINING THE NEXT GENERATION OF MENTAL HEALTH RESEARCHERS$216,000
R25 · FY2022 · MH
Secondary data analysis of auditory steady-state response to explore the RDoC cognitive system constructs across the psychosis spectrum$76,650
R03 · FY2022 · MH
Secondary data analysis of auditory steady-state response to explore the RDoC cognitive system constructs across the psychosis spectrum$76,650
R03 · FY2021 · MH
9/9-Predictors and Mechanisms of Conversion to Psychosis$598,551
U01 · FY2018 · MH · contact PI
9/9-Predictors and Mechanisms of Conversion to Psychosis$661,106
U01 · FY2017 · MH · contact PI
9/9-Predictors and Mechanisms of Conversion to Psychosis$906,176
U01 · FY2016 · MH · contact PI
Improving Frontal Emotion Regulation in PTSD by Targeting Sleep$763,021
R56 · FY2016 · MH
9/9-Predictors and Mechanisms of Conversion to Psychosis$804,090
U01 · FY2015 · MH · contact PI
Visual and Motor Neuroplasticity in Schizophrenia$191,625
R21 · FY2015 · MH · contact PI
9/9-Predictors and Mechanisms of Conversion to Psychosis$118,245
U01 · FY2015 · MH · contact PI
9/9-Predictors and Mechanisms of Conversion to Psychosis$818,131
U01 · FY2014 · MH · contact PI
Visual and Motor Neuroplasticity in Schizophrenia$229,950
R21 · FY2014 · MH · contact PI
Functional Brain Abnormalities in the Schizophrenia Prodrome$102,276
R01 · FY2014 · MH · contact PI
Applying Mindfulness-Based Cognitive Therapy to Treatment-Resistant Depression$156,174
R01 · FY2012 · AT
Applying Mindfulness-Based Cognitive Therapy to Treatment-Resistant Depression$484,140
R01 · FY2011 · AT
Functional Brain Abnormalities in the Schizophrenia Prodrome$473,947
R01 · FY2011 · MH · contact PI
Functional Brain Abnormalities in the Schizophrenia Prodrome$478,731
R01 · FY2010 · MH · contact PI
Functional Brain Abnormalities in the Schizophrenia Prodrome$464,740
R01 · FY2009 · MH · contact PI
Functional Brain Abnormalities in the Schizophrenia Prodrome$449,506
R01 · FY2008 · MH · contact PI
Functional Brain Abnormalities in the Schizophrenia Prodrome$315,403
R01 · FY2007 · MH · contact PI
Intermittent D1 Agonist Treatment of Executive Dysfunction in Schizophrenia: A Do$276,528
P50 · FY2005 · MH
Intermittent D1 Agonist Treatment of Executive Dysfunction in Schizophrenia: A Do$270,506
P50 · FY2004 · MH